Patients with ZKSCAN3(2+/3+) (p = 0.002) or ZKSCAN3(3+) (p < 0.001) tumor had a significantly higher risk of biochemical recurrence after radical prostatectomy, compared to those with ZKSCAN3(0/1+) or ZKSCAN3(0/1+/2+) tumor, respectively (Figure 3B). Here, ZKSCAN3 is linked to neoplasm.